Conmed share price today

(CNMD)

Conmed share price is $69.18 & ₹5,886.87 as on 24 Dec 2024, 2.30 'hrs' IST

$69.18

▲

0.55

(0.8%)

Market is closed - opens 8 PM, 24 Dec 2024

View live Conmed share price in Dollar and Rupees. Guide to invest in Conmed from India. Also see the sentimental analysis on Indian investors investing in Conmed. Get details on the Indian mutual funds that are investing in Conmed. Get Analyst recommendations and forecasts along with all the Conmed's financials.

Conmed share price movements

Today's Low: $67.13
Today's High: $69.47
$69.18
2.96%
Downside
Day's Volatility :3.37%
Upside
0.42%
52 Weeks Low: $61.05
52 Weeks High: $114.80
$69.18
11.75%
Downside
52 Weeks Volatility :46.82%
Upside
39.74%

Conmed Returns

Period	Conmed Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-9.27%	-10.0%	0.0%
6 Months	3.38%	-5.7%	0.0%
1 Year	-39.11%	2.8%	0.0%
3 Years	-51.76%	-0.4%	-21.1%

Conmed Key Statistics

in dollars & INR

Previous Close	$68.63
Open	$68.28
Today's High	$69.4699
Today's Low	$67.13
Market Capitalization	$2.1B
Today's Volume	$391.8K
52 Week High	$114.8
52 Week Low	$61.05
Revenue TTM	$1.3B
EBITDA	$217.8M
Earnings Per Share (EPS)	$4.22
PE Ratio	16.39
Dividend Yield	1.17%
Profit Margin	10.23%
Quarterly Earnings Growth YOY	2.14%
Return On Equity TTM	15.24%

How to invest in Conmed from India?

It is very easy for Indian residents to invest directly in Conmed from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Conmed stock in both Indian Rupees (INR) and US Dollars (USD). Search for Conmed or CNMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Conmed or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Conmed shares which would translate to 0.012 fractional shares of Conmed as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Conmed, in just a few clicks!

Returns in Conmed for Indian investors in Rupees

Investment Value

₹1,00,000

Conmed investment value today

Current value as on today

₹63,209

Returns

₹36,791

(-36.79%)

Returns from Conmed Stock

₹39,113 (-39.11%)

Dollar Returns

₹2,322 (+2.32%)

Indian investors sentiment towards Conmed

-25%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Search volume for Conmed on INDmoney from India has reduced in the last 30 days as on Dec 24, 2024. -25% less investors are searching Conmed in the last 30 days versus the previous period.

Global Institutional Holdings in Conmed

BlackRock Inc
16.17%
Vanguard Group Inc
11.43%
Earnest Partners LLC
9.01%
Capital Research Global Investors
5.00%
Bank of America Corp
4.44%
Champlain Investment Partners, LLC
4.43%

Analyst Recommendation on Conmed

Buy

71%Buy

28%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Conmed(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Conmed

What analysts predicted

Upside of 17.29%

Current:

$69.18

Target:

$81.14

Insights on Conmed

Price Movement
In the last 1 year, CNMD stock has moved down by -38.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 330.74M → 316.70M (in $), with an average decrease of 4.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 19.70M → 48.98M (in $), with an average increase of 36.5% per quarter
CNMD vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 60.8% return, outperforming this stock by 99.5%
CNMD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 110.3% return, outperforming this stock by 161.6%
Price to Sales
ForCNMD every $1 of sales, investors are willing to pay $1.7, whereas for Boston Scientific Corp., the investors are paying $8.3 for every $1 of sales.

Conmed Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$859.6M	↑ 7.94%
Net Income	$40.9M	↓ 26.37%
Net Profit Margin	4.75%	↓ 2.22%

	FY19	Y/Y Change
Revenue	$955.1M	↑ 11.11%
Net Income	$28.6M	↓ 29.95%
Net Profit Margin	3.0%	↓ 1.75%

	FY20	Y/Y Change
Revenue	$862.5M	↓ 9.7%
Net Income	$9.5M	↓ 66.75%
Net Profit Margin	1.1%	↓ 1.9%

	FY21	Y/Y Change
Revenue	$1.0B	↑ 17.18%
Net Income	$62.5M	↑ 557.16%
Net Profit Margin	6.19%	↑ 5.09%

	FY22	Y/Y Change
Revenue	$1.0B	↑ 3.45%
Net Income	$-80.6M	↓ 228.84%
Net Profit Margin	-7.71%	↓ 13.9%

	FY23	Y/Y Change
Revenue	$1.2B	↑ 19.06%
Net Income	$64.5M	↓ 179.99%
Net Profit Margin	5.18%	↑ 12.89%

	Q2 FY23	Q/Q Change
Revenue	$317.7M	↑ 7.51%
Net Income	$13.7M	↑ 654.92%
Net Profit Margin	4.32%	↑ 3.7%

	Q3 FY23	Q/Q Change
Revenue	$304.6M	↓ 4.12%
Net Income	$15.8M	↑ 15.33%
Net Profit Margin	5.2%	↑ 0.88%

	Q4 FY23	Q/Q Change
Revenue	$327.0M	↑ 7.38%
Net Income	$33.1M	↑ 108.82%
Net Profit Margin	10.11%	↑ 4.91%

	Q1 FY24	Q/Q Change
Revenue	$311.6M	↓ 4.71%
Net Income	$19.7M	↓ 40.4%
Net Profit Margin	6.32%	↓ 3.79%

	Q2 FY24	Q/Q Change
Revenue	$330.7M	↑ 6.13%
Net Income	$30.0M	↑ 52.09%
Net Profit Margin	9.06%	↑ 2.74%

	Q3 FY24	Q/Q Change
Revenue	$316.7M	↓ 4.25%
Net Income	$49.0M	↑ 63.41%
Net Profit Margin	15.47%	↑ 6.41%

	FY18	Y/Y Change
Profit	$469.1M	↑ 8.83%

	FY19	Y/Y Change
Profit	$524.7M	↑ 11.85%

	FY20	Y/Y Change
Profit	$460.3M	↓ 12.28%

	FY21	Y/Y Change
Profit	$568.0M	↑ 23.41%

	FY22	Y/Y Change
Profit	$571.2M	↑ 0.56%

	FY23	Y/Y Change
Profit	$676.2M	↑ 18.38%

	Q2 FY23	Q/Q Change
Profit	$170.7M	↑ 9.89%

	Q3 FY23	Q/Q Change
Profit	$168.1M	↓ 1.54%

	Q4 FY23	Q/Q Change
Profit	$184.3M	↑ 9.68%

	Q1 FY24	Q/Q Change
Profit	$162.0M	↓ 12.13%

	Q2 FY24	Q/Q Change
Profit	$173.2M	↑ 6.9%

	Q3 FY24	Q/Q Change
Profit	$179.0M	↑ 3.37%

	FY18	Y/Y Change
Operating Cash Flow	$74.7M	↑ 13.93%
Investing Cash Flow	$-16.5M	↓ 43.19%
Financing Cash Flow	$-72.3M	↑ 107.18%

	FY19	Y/Y Change
Operating Cash Flow	$95.1M	↑ 27.35%
Investing Cash Flow	$-387.7M	↑ 2248.47%
Financing Cash Flow	$300.9M	↓ 516.36%

	FY20	Y/Y Change
Operating Cash Flow	$64.5M	↓ 32.17%
Investing Cash Flow	$-13.6M	↓ 96.48%
Financing Cash Flow	$-52.1M	↓ 117.3%

	FY21	Y/Y Change
Operating Cash Flow	$111.8M	↑ 73.2%
Investing Cash Flow	$-14.9M	↑ 9.0%
Financing Cash Flow	$-101.5M	↑ 95.06%

	FY22	Y/Y Change
Operating Cash Flow	$33.4M	↓ 70.15%
Investing Cash Flow	$-249.5M	↑ 1578.52%
Financing Cash Flow	$225.0M	↓ 321.57%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$26.7M	↓ 793.35%
Investing Cash Flow	$-5.5M	↑ 29.97%
Financing Cash Flow	$-19.8M	↓ 469.85%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$46.1M	↑ 72.94%
Investing Cash Flow	$-5.4M	↓ 2.44%
Financing Cash Flow	$-37.2M	↑ 88.15%

Conmed Technicals Summary

Sell

Neutral

Buy

Conmed is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Conmed Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Conmed Corp	-10.78%	3.38%	-39.11%	-51.76%	-50.03%
Stryker Corporation	-4.79%	7.93%	22.54%	35.53%	74.73%
Boston Scientific Corp.	0.68%	15.93%	60.49%	108.4%	98.54%
Edwards Lifesciences Corp.	4.97%	-17.86%	-1.93%	-42.71%	-4.81%
Abbott Laboratories	-3.23%	8.36%	4.65%	-19.19%	30.97%
Medtronic Plc	-5.07%	1.23%	-1.09%	-22.05%	-27.7%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Conmed Corp	16.39	16.39	5.29	4.03	0.15	0.04	0.01	30.21
Stryker Corporation	39.08	39.08	2.55	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.51	73.51	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.87	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.72	34.72	2.21	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.78	24.78	1.48	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Conmed Corp	Buy	$2.1B	-50.03%	16.39	10.23%
Stryker Corporation	Buy	$139.0B	74.73%	39.08	16.34%
Boston Scientific Corp.	Buy	$131.1B	98.54%	73.51	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-4.81%	28.88	65.86%
Abbott Laboratories	Buy	$198.1B	30.97%	34.72	13.99%
Medtronic Plc	Buy	$103.9B	-27.7%	24.78	12.06%

Conmed Dividend announcements

Conmed Dividends December, 2024
In the quarter ending December,2024. Conmed has declared dividend of $0.20
Read More

About Conmed

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500

Organization	Conmed
Employees	4000
CEO	Mr. Curt R. Hartman
Industry	Health Technology

Management People of Conmed

Name	Title
Mr. Curt R. Hartman	President, CEO & Director
Mr. Todd W. Garner CPA	Executive VP, CFO & Principal Accounting Officer
Mr. Patrick J. Beyer	Chief Operating Officer
Mr. Richard Glaze	Chief Information Officer
Hollie Foust	General Counsel & Corporate Secretary
Mr. Peter K. Shagory	Executive Vice President of Strategy & Corporate Development
Ms. Shanna L. Cotti-Osmanski	Executive VP of Information Technology & CIO
Mr. John Ferrell	Executive Vice President of Human Resources
Mr. David R. Murray	President of ConMed Electrosurgery
Ms. Johonna Marie Pelletier CPA	VP of Tax & Treasurer

Important FAQs about investing in Conmed from India :

What is Conmed share price today?

Conmed share price today stands at $69.18, Open: $68.28 ; Previous Close: $68.63 ; High: $69.47 ; Low: $67.13 ; 52 Week High: $114.80 ; 52 Week Low: $61.05. The stock opens at $68.28, after a previous close of $68.63. The stock reached a daily high of $69.47 and a low of $67.13, with a 52-week high of $114.80 and a 52-week low of $61.05.

Can Indians buy Conmed shares?

Yes, Indians can invest in the Conmed (CNMD) from India.

With INDmoney, you can buy Conmed at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Conmed at zero transaction cost.

How can I buy Conmed shares from India?

It is very easy to buy Conmed from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Conmed be purchased?

Yes, you can buy fractional shares of Conmed with INDmoney app.

What are the documents required to start investing in Conmed stocks?

To start investing in Conmed, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.